What's new
Walk to raise awareness on the prevention of diabetes
We remember our Participation in the Walk to raise awareness on the prevention of Diabetes organized by Dr. Felix Manuel Seat, president of the Foundation of the Dominican Endocrinology and Diabetes.
It is our commitment to the society and the patients living with this condition, providing health solutions contribute to the quality of life. With the technology of the test Innovatio ND2, identifies the risk to Develop Diabetic Kidney Disease (DKD)with up to 4 years in advance.
Walk to raise awareness on the prevention of diabetes
The Minister of Industry, Commerce and Msmes, Itó Bisonó, met my first-hand the operation of Macrotech, recognizing the unique system of clinical care to patients with chronic renal diseases.
1st Consensus on Risk Stratification of Acute Kidney Injury in the critical patient in the Dominican Republic
We share with pride in our participation in the 1st Consensus on Risk Stratification of Acute Kidney Injury in the critical patient in the Dominican Republic” within the framework of the Congress of Nephrology 2021.
Through this agreement, we create awareness of the impact of acute kidney injury, and to facilitate their detection and timely intervention; already the acute kidney injury increases the costs, time of hospitalization, duration of convalescence, and the probability of death. Highlighting the importance of a multidisciplinary team in the management of acute kidney injury.
Macrotech and Baxter Made Lunch Conference on Peritoneal Dialysis (PD) Moderna; in the framework of the Congress of the Dominican republic of Nephrology.
Presentation with Baxter of the new advances in the care of patients with chronic kidney disease in the lunch Peritoneal Dialysis Moderna; made in the framework of the Congress of the Dominican republic of Nephrology that was performed during days 23 to 26 September 2021.
With the participation of over 200 physicians, national and international.
The DP moderna has a positive impact for more than 78% of people with chronic kidney disease because it has better survival outcomes comparable or superior to the HD.